Ildefonso Cerrillo-Sanchez
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Combined dendritic cell and anti-TIGIT immunotherapy potentiates adaptive NK cells against HIV-1.
Journal: EMBO molecular medicine
Published: November 27, 2024
Single-cell multi-omics analysis of COVID-19 patients with pre-existing autoimmune diseases shows aberrant immune responses to infection.
Journal: European journal of immunology
Published: June 28, 2023
NFκB and NLRP3/NLRC4 inflammasomes regulate differentiation, activation and functional properties of monocytes in response to distinct SARS-CoV-2 proteins.
Journal: Nature communications
Published: April 14, 2023
MICa/b-dependent activation of natural killer cells by CD64+ inflammatory type 2 dendritic cells contributes to autoimmunity.
Journal: The EMBO journal
Published: February 08, 2023
KLRG1 expression on natural killer cells is associated with HIV persistence, and its targeting promotes the reduction of the viral reservoir.
Journal: Cell reports. Medicine
Published: February 08, 2023
Antiretroviral therapy duration and immunometabolic state determine efficacy of ex vivo dendritic cell-based treatment restoring functional HIV-specific CD8+ T cells in people living with HIV.
Journal: EBioMedicine
Published: February 11, 2022
Poly I:C and STING agonist-primed DC increase lymphoid tissue polyfunctional HIV-1-specific CD8+ T cells and limit CD4+ T-cell loss in BLT mice.
Journal: European journal of immunology
Published: July 12, 2021
Deregulated cellular circuits driving immunoglobulins and complement consumption associate with the severity of COVID-19 patients.
Journal: European journal of immunology
Published: July 01, 2020
Differential Redistribution of Activated Monocyte and Dendritic Cell Subsets to the Lung Associates with Severity of COVID-19.
Journal: medRxiv : the preprint server for health sciences
Published: June 09, 2020
IL-6 serum levels predict severity and response to tocilizumab in COVID-19: An observational study.
Journal: The Journal of allergy and clinical immunology
Published: May 29, 2020
Last Updated: 09/26/2026